[(18)F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy

PURPOSE: Positron emission tomography (PET) with [(18)F]fluorodeoxyglucose (FDG-PET) has increasingly been used to evaluate the efficacy of anticancer agents. We investigated the role of FDG-PET as a predictive marker for response to mammalian target of rapamycin (mTOR) inhibition in advanced solid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Ma, Wen Wee, Jacene, Heather, Song, Dongweon, Vilardell, Felip, Messersmith, Wells A., Laheru, Dan, Wahl, Richard, Endres, Chris, Jimeno, Antonio, Pomper, Martin G., Hidalgo, Manuel
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2689846/
https://ncbi.nlm.nih.gov/pubmed/19380450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.8383
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados